Insiders · RMTI

Mark Strobeck

President and CEO at Rockwell Medical, Inc. (RMTI) since July 2022

Mark Strobeck has filed 21 insider reports with the SEC since July 2022, as president and CEO at Rockwell Medical, Inc. (RMTI) and director at Windtree Therapeutics Inc /de/ (WINT). Mark Strobeck made no open-market purchases or sales in the last 12 months. The latest filing, on October 1, 2026, is a Form 144 notice: Mark Strobeck plans to sell 1,000 RMTI shares (~$8,400).

Planned sale (Form 144)

  • Mark Strobeck plans to sell 1,000 RMTI shares (~$8,400), around Oct 1, 2026. Notice filed Oct 1, 2026.

A Form 144 is a notice of a proposed sale, not a trade. The sale itself shows up in a later Form 4.

Filings
21
Companies
2
Bought on market
None
Sold on market
$39.5K

Companies where Mark Strobeck is an insider

CompanyRoleShares heldBoughtSoldAvg buyPrice nowLast filing
Rockwell Medical, Inc. logo
RMTI
Rockwell Medical, Inc.
President and CEOsince July 202262,349$39.5K$6.10Oct 1, 2026
Windtree Therapeutics Inc /de/ logo
WINT
Windtree Therapeutics Inc /de/
Directorsince June 20232,300Aug 25, 2023

Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.

Every filing

Compare Mark Strobeck with

Other insiders at the same companies

Questions about Mark Strobeck

What is Mark Strobeck's role at Rockwell Medical, Inc.?
Mark Strobeck reports to the SEC as president and CEO at Rockwell Medical, Inc. (RMTI), according to the latest filing on October 1, 2026. Mark Strobeck has also filed as director at Windtree Therapeutics Inc /de/ (WINT).
How many shares does Mark Strobeck own?
After the latest filing that states it, Mark Strobeck directly owned 62,349 shares of Rockwell Medical, Inc. (RMTI) and 2,300 shares of Windtree Therapeutics Inc /de/ (WINT). Shares held through trusts, funds or family members are reported separately and are not counted here.
Has Mark Strobeck bought or sold stock recently?
The most recent open-market sale was on October 1, 2025: sold 6,926 shares of Rockwell Medical, Inc. (RMTI) for $8,242 at an average of $1.19.
How do I get alerts when Mark Strobeck files?
Follow Mark Strobeck on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale. Mark Strobeck filed 1 time in the last 90 days.

From SEC Forms 3, 4, 5 and 144 filed by Mark Strobeck (SEC CIK 0001599219). Totals count each trade once, skipping amendments whose original is on file, from Jul 5, 2022 on. View on SEC EDGAR